Bio Reference Laboratories Inc Financial Statements (2025 and earlier)
Company Profile
| Business Address |
481 EDWARD H ROSS DR ELMWOOD PARK, NJ 07407-3118 |
| State of Incorp. | NJ |
| Fiscal Year End | October 31 |
| Industry (SIC) | 8071 - Medical Laboratories (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 4/30/2015 MRQ | 10/31/2014 | 10/31/2013 | 10/31/2012 | |||
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Current Assets | ||||||
| Cash, cash equivalents, and short-term investments | 17,507 | 17,952 | 25,143 | |||
| Cash and cash equivalents | 17,507 | 17,952 | 25,143 | |||
| Receivables | 263,346 | 206,261 | 153,247 | |||
| Inventory, net of allowances, customer advances and progress billings | 20,791 | 19,095 | 14,902 | |||
| Inventory | 20,791 | 19,095 | 14,902 | |||
| Other current assets | 10,165 | ✕ | ||||
| Prepaid expense and other current assets | ✕ | ✕ | 9,416 | 5,373 | ||
| Other undisclosed current assets | 40,040 | 42,154 | 24,912 | |||
| Total current assets: | 351,849 | 294,878 | 223,577 | |||
| Noncurrent Assets | ||||||
| Property, plant and equipment | 66,388 | 65,649 | 50,440 | |||
| Long-term investments and receivables | 5,153 | 5,237 | 4,977 | |||
| Long-term investments | 5,153 | 5,237 | 4,977 | |||
| Intangible assets, net (including goodwill) | 49,588 | 51,505 | 29,731 | |||
| Goodwill | 35,185 | 35,185 | 23,408 | |||
| Intangible assets, net (excluding goodwill) | 14,403 | 16,320 | 6,323 | |||
| Deposits noncurrent assets | 1,056 | 1,017 | 956 | |||
| Other noncurrent assets | 1,415 | ✕ | ||||
| Prepaid expense and other noncurrent assets | ✕ | ✕ | 1,165 | 866 | ||
| Other undisclosed noncurrent assets | (62,974) | (63,572) | (48,162) | |||
| Total noncurrent assets: | 60,626 | 61,001 | 38,808 | |||
| Other undisclosed assets | 66,388 | 65,649 | 50,440 | |||
| TOTAL ASSETS: | 478,863 | 421,528 | 312,825 | |||
| LIABILITIES AND EQUITY | ||||||
| Liabilities | ||||||
| Current Liabilities | ||||||
| Accounts payable and accrued liabilities | 102,608 | 99,507 | 67,531 | |||
| Taxes payable | 15,620 | 18,292 | 9,753 | |||
| Employee-related liabilities | 15,822 | 19,601 | 16,490 | |||
| Accounts payable | 71,166 | 61,614 | 41,288 | |||
| Debt | 6,652 | 5,678 | 4,421 | |||
| Other undisclosed current liabilities | 35,304 | 28,577 | ||||
| Total current liabilities: | 144,564 | 133,762 | 71,952 | |||
| Noncurrent Liabilities | ||||||
| Long-term debt and lease obligation | 15,397 | 14,382 | 13,626 | |||
| Long-term debt, excluding current maturities | 3,145 | 3,670 | 4,163 | |||
| Capital lease obligations | 12,252 | 10,712 | 9,463 | |||
| Other undisclosed noncurrent liabilities | 1,789 | |||||
| Total noncurrent liabilities: | 15,397 | 16,171 | 13,626 | |||
| Total liabilities: | 159,961 | 149,933 | 85,578 | |||
| Equity | ||||||
| Equity, attributable to parent | 318,902 | 271,595 | 227,247 | |||
| Common stock | 277 | 277 | 277 | |||
| Additional paid in capital | 39,979 | 39,430 | 40,907 | |||
| Retained earnings | 278,646 | 231,888 | 186,063 | |||
| Total equity: | 318,902 | 271,595 | 227,247 | |||
| TOTAL LIABILITIES AND EQUITY: | 478,863 | 421,528 | 312,825 | |||
Income Statement (P&L) ($ in thousands)
| 4/30/2015 TTM | 10/31/2014 | 10/31/2013 | 10/31/2012 | ||
|---|---|---|---|---|---|
| Revenues (Revenue, Net) | 832,282 | 715,354 | 661,661 | ||
| Cost of revenue (Cost of Goods and Services Sold) | (462,283) | (392,815) | (337,644) | ||
| Gross profit: | 369,999 | 322,539 | 324,017 | ||
| Operating expenses | (212,006) | (224,245) | (167,446) | ||
| Other undisclosed operating loss | (74,568) | (16,321) | (80,440) | ||
| Operating income: | 83,425 | 81,973 | 76,131 | ||
| Nonoperating expense | (2,541) | (264) | (1,938) | ||
| Investment income, nonoperating | (83) | 612 | (323) | ||
| Other nonoperating expense | (2,458) | (876) | (1,615) | ||
| Interest and debt expense | (2,446) | (1,606) | (1,455) | ||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 2,529 | 994 | 1,778 | ||
| Income from continuing operations before equity method investments, income taxes: | 80,967 | 81,097 | 74,516 | ||
| Loss from equity method investments | (83) | (450) | (323) | ||
| Income from continuing operations before income taxes: | 80,884 | 80,647 | 74,193 | ||
| Income tax expense | (34,209) | (35,272) | (32,360) | ||
| Income from continuing operations: | 46,675 | 45,375 | 41,833 | ||
| Income before gain (loss) on sale of properties: | 46,675 | 45,375 | 41,833 | ||
| Net income attributable to parent: | 46,675 | 45,375 | 41,833 | ||
| Other undisclosed net income available to common stockholders, basic | 83 | 450 | 323 | ||
| Net income available to common stockholders, diluted: | 46,758 | 45,825 | 42,156 | ||
Comprehensive Income ($ in thousands)
| 4/30/2015 TTM | 10/31/2014 | 10/31/2013 | 10/31/2012 | ||
|---|---|---|---|---|---|
| Net income: | 46,675 | 45,375 | 41,833 | ||
| Comprehensive income, net of tax, attributable to parent: | 46,675 | 45,375 | 41,833 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.